Keyword [CA19-9]
Result: 21 - 40 | Page: 2 of 10 |
| 21. | The Value Of FCM-DNA Ploidy Analysis And Many Tumor Markers In Diagnostic Benign And Malignant Pleuroperitoneal Fluids |
| 22. | Clinical Analysis In 237 Patients With Ascites |
| 23. | The Value Of CEA,CA19-9,CA72-4 Combine Examine In Gastric And Large Intestine Carcinoma Diagnosis |
| 24. | Study Of Serum Tumor Markers, Tissue Protein Expression And Their Relationship With Prognosis Of Gastric Cancer |
| 25. | Study Of TNF-α,CEA,CA125,CA19-9,CA72-4 In Serum For The Diagnosis Of Gastric Carcinoma |
| 26. | Diagnostic Value About The Level Of CA153 And CA99 In The Malignancy-Relted Ascites |
| 27. | The Significance Of Combined Detection Of AFP, CA19-9, CA125, CEA In Differential Diagnosis Of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma And Hepatic Hemangioma |
| 28. | The Application And Value Of Measuring Serum CA72-4, CA19-9, CEA Standard In Cure Of Gastric Carcinoma |
| 29. | How To Explore An Elevated Serum CA19-9 In General Health Examination Population |
| 30. | Determination Of Serum Tumor Markers In Lung Cancer Diagnosis |
| 31. | The Application And Value Of Measuring Serum CA72-4, CA19-9, CEA Standard In Cure Of Gastric Carcinoma |
| 32. | The Clinical Analysis Of Tumor Marker CA19-9 And CEA In Diagnosis Of Cholangiocarcinoma |
| 33. | The Diagnostic Values Of Bile Cytology And Blood Tumor Markers In Malignant Bile Duct Obstruction |
| 34. | Diagnostic Value Of Combined Detection Of Serum AFP,CEA,CA19-9 In Primary Hepatic Carcinoma |
| 35. | The Clinical Research On The Value Of Serum CA19-9 In Diagnosis Of Hepatobiliary And Pancreatic Diseases |
| 36. | The Clinical Significance Of CEA,CA19-9,CA72-4 For Evaluating The Efficacy Of Chemotherapy In Patients With Gastric Cancer |
| 37. | The Correlation Between CA19-9 And Type 2 Diabetes Mellitus |
| 38. | Clinical Significance Of Monitoring Preoperative CEA, CA125, CA19-9 And β HCG Serum Level In Esophageal Cancer |
| 39. | The Diagnostic Value Of Determination Of Serum HE4 Associated With CA125, CA19-9 In Patients With Ovarian Cancer |
| 40. | Studies On The Relativity Between MMP-9 Genetic Polymorphisms And Susceptibility Of Colorectal Cancer In Luzhou Area |
|
